Results 41 to 50 of about 3,197,416 (181)
Part 1: Evaluation of Pediatric Cannabis–Drug Interaction Reports
ABSTRACT Data addressing safety concerns related to potential drug interactions between cannabis‐derived products and pharmaceutical medications in the pediatric population are lacking. In this study, we retrieved case reports through a published literature search using PubMed and spontaneous reporting data using the Food and Drug Administration's ...
Maryann R. Chapin+7 more
wiley +1 more source
Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain [PDF]
Objectives. To explore the lived experience of youth, caregivers, and prescribers with antipsychotic medications. Design. We conducted a qualitative interpretive phenomenology study.
Cooke, Charmaine+5 more
core +3 more sources
ABSTRACT The increasing utilization of cannabis products combined with lack of data regarding potential cannabis–prescription drug interactions is concerning. This study aimed to review published case reports and FDA Adverse Event Reporting System (FAERS) spontaneous reports to assess cannabis–drug interactions in persons aged 18 and over. A literature
Maryann R. Chapin+7 more
wiley +1 more source
Efficacy and safety of endoxifen in bipolar disorder: A systematic review
Abstract Background Endoxifen, a protein kinase C inhibitor and selective estrogen receptor modulator, primarily used in breast cancer treatment, has recently emerged as a potential therapeutic option for managing manic episodes associated with bipolar disorder (BD).
Jithin Thekkelkuthiyathottil Joseph+2 more
wiley +1 more source
Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database [PDF]
Objective To assess associations between different antidepressant treatments and rates of three cardiovascular outcomes (myocardial infarction, stroke or transient ischaemic attack, and arrhythmia) in people with depression.
Arthur, Antony+5 more
core +2 more sources
Abstract Background Abnormalities in dopamine and norepinephrine signaling are implicated in cognitive impairments in bipolar disorder (BD) and attention‐deficit hyperactivity disorder (ADHD). This systematic review by the ISBD Targeting Cognition Task Force therefore aimed to investigate the possible benefits on cognition and/or ADHD symptoms and ...
Kamilla W. Miskowiak+27 more
wiley +1 more source
Polycystic ovary syndrome in women using valproate: a review.
Valproate (VPA) is a highly effective drug successfully employed in several neuropsychiatric diseases. In the last 15 years, an increased prevalence of polycystic ovary syndrome (PCOS) associated with VPA use has been reported in both women with epilepsy
Bilo L., Meo R.
core +1 more source
Patterns of pharmacotherapy for bipolar disorder: A GBC survey
Abstract Objectives To understand treatment practices for bipolar disorders (BD), this study leveraged the Global Bipolar Cohort collaborative network to investigate pharmacotherapeutic treatment patterns in multiple cohorts of well‐characterized individuals with BD in North America, Europe, and Australia. Methods Data on pharmacotherapy, demographics,
Balwinder Singh+44 more
wiley +1 more source
The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
The cellular basis underlying the complex clinical symptomatology of bipolar disorder and the mechanisms underlying the actions of its effective treatments have not yet been fully elucidated.
Jing Du+13 more
semanticscholar +1 more source
Challenges in defining treatment‐resistant mania in adults: A systematic review
Abstract Objectives To review the definitions of treatment‐resistant mania (TRM) in the literature and propose criteria for an operationalized definition. Methods A systematic search of five databases (MEDLINE, EMBASE, PsychInfo, Cochrane Central, and CINAHL) and data extraction of eligible articles. Results In total, 47 articles addressing the concept
Christina Gonzalez‐Torres+5 more
wiley +1 more source